X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
index medicus (40) 40
microbiology (39) 39
infectious diseases (37) 37
female (30) 30
immunology (30) 30
male (24) 24
animals (20) 20
adult (19) 19
influenza (19) 19
child (16) 16
middle aged (16) 16
viruses (16) 16
aged (15) 15
canada - epidemiology (15) 15
child, preschool (15) 15
infant (15) 15
adolescent (14) 14
influenza, human - epidemiology (14) 14
influenza, human - virology (14) 14
molecular sequence data (14) 14
research (14) 14
virus (13) 13
young adult (13) 13
aged, 80 and over (12) 12
biochemistry (11) 11
chemistry (11) 11
general tagging of cross-sectional technologies spanning over several sections of the ipc (11) 11
general tagging of new technological developments (11) 11
human necessities (11) 11
hygiene (11) 11
infection (11) 11
influenza, human - prevention & control (11) 11
medical or veterinary science (11) 11
metallurgy (11) 11
organic chemistry (11) 11
peptides (11) 11
preparations for medical, dental, or toilet purposes (11) 11
sentinel surveillance (11) 11
sequence analysis, dna (11) 11
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (11) 11
technologies for adaptation to climate change (11) 11
technologies or applications for mitigation or adaptation againstclimate change (11) 11
virology (11) 11
basic electric elements (10) 10
beer (10) 10
canada (10) 10
children (10) 10
compositions thereof (10) 10
culture media (10) 10
devices using stimulated emission (10) 10
electricity (10) 10
enzymology (10) 10
epidemiology (10) 10
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (10) 10
microorganisms or enzymes (10) 10
mutation or genetic engineering (10) 10
processes using microorganisms (10) 10
propagating, preserving or maintaining microorganisms (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
spirits (10) 10
technical subjects covered by former uspc (10) 10
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (10) 10
united-states (10) 10
vaccine effectiveness (10) 10
vaccines (10) 10
vinegar (10) 10
wine (10) 10
base sequence (9) 9
influenza vaccines - immunology (9) 9
mice (9) 9
quebec - epidemiology (9) 9
abridged index medicus (8) 8
biochemistry & molecular biology (8) 8
efficacy (8) 8
epidemics (8) 8
hemagglutination inhibition tests (8) 8
identification (8) 8
infections (8) 8
influenza vaccines - administration & dosage (8) 8
medicine (8) 8
phylogeny (8) 8
public health (8) 8
amino acid sequence (7) 7
case-control studies (7) 7
cluster analysis (7) 7
genotype (7) 7
hiv-1 - genetics (7) 7
immunization (7) 7
influenza a virus, h1n1 subtype - isolation & purification (7) 7
influenza b virus - isolation & purification (7) 7
influenza vaccines (7) 7
leishmania donovani - genetics (7) 7
prevention (7) 7
age (6) 6
disease transmission (6) 6
infant, newborn (6) 6
influenza, human - diagnosis (6) 6
mice, inbred c57bl (6) 6
pandemics (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2007, Volume 195, Issue 7, pp. 951 - 959
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e92153
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 04/2017, Volume 215, Issue 7, pp. 1059 - 1099
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2017, Volume 216, Issue 12, pp. 1487 - 1500
Vaccine effectiveness estimates for 2015–2016 seasonal influenza vaccine are reported from Canada. Findings suggest that agent-host and immuno-epidemiologic... 
original antigenic sin | vaccine effectiveness | influenza vaccine | hemagglutination inhibition | birth cohort effects | influenza A subtype | repeat vaccination | influenza B lineage | Influenza | sequencing | UNITED-STATES | STRAINS | INFECTIOUS DISEASES | VIRUS | METAANALYSIS | HEMAGGLUTININ | PROTECTION | ANTIBODY | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | SURVEILLANCE | INFECTION | Immunogenicity, Vaccine | Influenza A Virus, H1N1 Subtype - immunology | Influenza Vaccines - administration & dosage | Influenza A Virus, H1N1 Subtype - classification | Age Factors | Humans | Middle Aged | Child, Preschool | Infant | Male | Phylogeny | Hemagglutination Inhibition Tests | Sequence Homology | Young Adult | Influenza B virus - genetics | Canada - epidemiology | Influenza A Virus, H1N1 Subtype - isolation & purification | Aged, 80 and over | Adult | Female | Influenza, Human - virology | Influenza B virus - immunology | Child | Influenza A Virus, H1N1 Subtype - genetics | Influenza B virus - classification | Antigenic Variation | Immunization - methods | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Treatment Outcome | Sequence Analysis, DNA | Antigens, Viral - immunology | Influenza Vaccines - immunology | Aged | Influenza, Human - prevention & control | Cluster Analysis | Influenza vaccines | Epidemics | Canada | Care and treatment | Usage | Analysis | Antigenic determinants | Major and Brief Reports
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2014, Volume 210, Issue 1, pp. 126 - 137
Background. We estimate vaccine effectiveness (VE) against both influenza A/subtypes and B/lineages in Canada for the 2011-2012 trivalent inactivated influenza... 
Influenza vaccines | Viral vaccines | Influenza A virus | Comorbidity | Sentinel surveillance | Vaccine components | Specimens | Viruses | Inactivated vaccines | H3N2 subtype influenza A virus | Influenza A subtype | Influenza B lineage | Influenza | Vaccine effectiveness | Vaccines and immunisation | Trivalent influenza vaccine | influenza | INFECTIOUS DISEASES | NETWORK | vaccines and immunisation | VIRUS | CANADA | influenza A subtype | EFFICACY | trivalent influenza vaccine | PERSISTENCE | ANTIBODY | MICROBIOLOGY | sentinel surveillance | IMMUNOLOGY | vaccine effectiveness | influenza B lineage | SENTINEL SURVEILLANCE SYSTEM | PANDEMIC H1N1 VACCINE | Influenza Vaccines - administration & dosage | Humans | Influenza A virus - genetics | Middle Aged | Child, Preschool | Molecular Sequence Data | Antigens, Viral - genetics | Infant | Male | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Case-Control Studies | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Hemagglutination Inhibition Tests | Young Adult | Influenza B virus - genetics | Vaccination - methods | Canada - epidemiology | Aged, 80 and over | Adult | Female | Influenza A virus - immunology | Influenza, Human - virology | Influenza B virus - immunology | Child | Influenza B virus - classification | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Treatment Outcome | Influenza A virus - isolation & purification | Sequence Analysis, DNA | Antigens, Viral - immunology | Influenza Vaccines - immunology | Adolescent | Aged | Influenza A virus - classification | Influenza, Human - prevention & control | Influenza, Human - immunology | Care and treatment | Analysis | Research | Health aspects | Sentinel health events
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2012, Volume 55, Issue 3, pp. 332 - 342
Journal Article
Journal Article
Virology, ISSN 0042-6822, 11/2019, Volume 537, pp. 65 - 73
West Nile virus (WNV) was introduced for the first time in the western hemisphere in 1999 in New York City. In 2002, a phenotype-modifying mutation (Env-V159A)... 
West Nile virus | Genotype | Phylogenic analysis | Mutation | Arbovirus | Genome | Mosquito vector | Amino acid substitution | MIGRATION | USA | INFERENCE | NONSTRUCTURAL PROTEIN NS2A | EVOLUTION | VIROLOGY | DYNAMICS | DENGUE VIRUS | BIRDS
Journal Article